TSH Biopharm Corporation Statistics

Total Valuation

TPEX:8432 has a market cap or net worth of TWD 1.94 billion. The enterprise value is 1.62 billion.

Market Cap	1.94B
Enterprise Value	1.62B

Important Dates

The last earnings date was Monday, May 5, 2025.

Earnings Date	May 5, 2025
Ex-Dividend Date	Jun 17, 2024

Share Statistics

TPEX:8432 has 38.40 million shares outstanding. The number of shares has increased by 0.06% in one year.

Current Share Class	38.40M
Shares Outstanding	38.40M
Shares Change (YoY)	+0.06%
Shares Change (QoQ)	+0.11%
Owned by Insiders (%)	1.03%
Owned by Institutions (%)	0.66%
Float	15.12M

Valuation Ratios

The trailing PE ratio is 18.91.

PE Ratio	18.91
Forward PE	n/a
PS Ratio	1.61
PB Ratio	1.18
P/TBV Ratio	1.75
P/FCF Ratio	12.56
P/OCF Ratio	12.32
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.78, with an EV/FCF ratio of 10.51.

EV / Earnings	15.79
EV / Sales	1.35
EV / EBITDA	8.78
EV / EBIT	9.61
EV / FCF	10.51

Financial Position

The company has a current ratio of 5.86, with a Debt / Equity ratio of 0.01.

Current Ratio	5.86
Quick Ratio	3.52
Debt / Equity	0.01
Debt / EBITDA	0.06
Debt / FCF	0.07
Interest Coverage	269.18

Financial Efficiency

Return on equity (ROE) is 8.79% and return on invested capital (ROIC) is 6.82%.

Return on Equity (ROE)	8.79%
Return on Assets (ROA)	6.15%
Return on Invested Capital (ROIC)	6.82%
Return on Capital Employed (ROCE)	10.21%
Revenue Per Employee	15.82M
Profits Per Employee	1.35M
Employee Count	76
Asset Turnover	0.70
Inventory Turnover	3.82

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -23.79% in the last 52 weeks. The beta is 0.25, so TPEX:8432's price volatility has been lower than the market average.

Beta (5Y)	0.25
52-Week Price Change	-23.79%
50-Day Moving Average	52.21
200-Day Moving Average	58.84
Relative Strength Index (RSI)	52.54
Average Volume (20 Days)	35,902

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:8432 had revenue of TWD 1.20 billion and earned 102.58 million in profits. Earnings per share was 2.67.

Revenue	1.20B
Gross Profit	608.79M
Operating Income	168.51M
Pretax Income	173.08M
Net Income	102.58M
EBITDA	184.46M
EBIT	168.51M
Earnings Per Share (EPS)	2.67

Full Income Statement

Balance Sheet

The company has 562.46 million in cash and 10.50 million in debt, giving a net cash position of 551.96 million or 14.37 per share.

Cash & Cash Equivalents	562.46M
Total Debt	10.50M
Net Cash	551.96M
Net Cash Per Share	14.37
Equity (Book Value)	1.64B
Book Value Per Share	36.48
Working Capital	1.10B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 157.09 million and capital expenditures -2.96 million, giving a free cash flow of 154.13 million.

Operating Cash Flow	157.09M
Capital Expenditures	-2.96M
Free Cash Flow	154.13M
FCF Per Share	4.01

Full Cash Flow Statement

Margins

Gross margin is 50.63%, with operating and profit margins of 14.01% and 8.53%.

Gross Margin	50.63%
Operating Margin	14.01%
Pretax Margin	14.39%
Profit Margin	8.53%
EBITDA Margin	15.34%
EBIT Margin	14.01%
FCF Margin	12.82%

Dividends & Yields

This stock pays an annual dividend of 2.12, which amounts to a dividend yield of 4.21%.

Dividend Per Share	2.12
Dividend Yield	4.21%
Dividend Growth (YoY)	-20.00%
Years of Dividend Growth	n/a
Payout Ratio	47.92%
Buyback Yield	-0.06%
Shareholder Yield	4.15%
Earnings Yield	5.30%
FCF Yield	7.96%

Dividend Details

Stock Splits

The last stock split was on August 28, 2013. It was a forward split with a ratio of 1.1.

Last Split Date	Aug 28, 2013
Split Type	Forward
Split Ratio	1.1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a